Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Abvc Biopharma (ABVC) posted Depreciation & Amortization (CF) of $6,906 for Q3 2026, down 72.7% from $25,330 a year earlier and down 43.8% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Depreciation & Amortization (CF) at Abvc Biopharma was $30,779, down 37.8% year-over-year; for FY2025, it came in at $25,330, down 20.9% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -7.4% (FY2020 to FY2025).
  • In prior years, Abvc Biopharma's Depreciation & Amortization (CF) was $32,025 in FY2024 (+12.2%), $28,531 in FY2023 (+19.9%), $23,799 in FY2022 (+98.4%) and $11,993 in FY2021 (-67.7%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $1,286 in Q1 2024 to a high of $28,627 in Q3 2024 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in three of the last eight quarters, with growth averaging 46.4%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q1 2025, with growth of 446.0%; the weakest was Q1 2024, with a decline of 80.2%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $12,299 (Q2 2026), $5,783 (Q1 2026) and $5,791 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.12 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 192.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 132.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 1.58 Bn
10 Abvc Biopharma 24.28 Mn 21.86 Mn - 6,906.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6,906.00
Jun 30, 2026 12,299.00
Mar 31, 2026 5,783.00
Dec 31, 2025 5,791.00
Sep 30, 2025 25,330.00
Jun 30, 2025 6,697.00
Mar 31, 2025 7,021.00
Dec 31, 2024 10,420.00
Sep 30, 2024 28,627.00
Jun 30, 2024 13,305.00
Mar 31, 2024 1,286.00
Dec 31, 2023 7,582.00
Sep 30, 2023 7,459.00
Jun 30, 2023 6,997.00
Mar 31, 2023 6,493.00
Dec 31, 2022 6,435.00
Sep 30, 2022 6,462.00
Jun 30, 2022 5,491.00
Mar 31, 2022 5,411.00
Dec 31, 2021 3,268.00
API Access

Abvc Biopharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ABVC&period=max&api_key=YOUR_API_KEY